Richard J Rodgers Ocuphire Pharma, Inc. (OCUP) insider trading activity

Richard J Rodgers is of Ocuphire Pharma, Inc.. Currently has a direct ownership of 239,151 shares of OCUP, which is worth approximately $253,500. The most recent transaction as insider was on Jun 11, 2024, when has been sold 41,143 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 239K

0% 3M change

38.04% 12M change

Total Value Held $253,500

Richard J Rodgers Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 11 2024	BUY Grant, award, or other acquisition	-	41,143 Added 14.68%	239,151 Common Stock
Jan 01 2024	BUY Grant, award, or other acquisition	-	24,762 Added 11.12%	198,008 Common Stock
Nov 01 2023	BUY Grant, award, or other acquisition	-	35,000 Added 16.81%	173,246 Common Stock
Apr 19 2023	BUY Grant, award, or other acquisition	-	50,000 Added 26.56%	138,246 Common Stock
Jan 11 2023	BUY Grant, award, or other acquisition	-	20,822 Added 19.09%	88,246 Common Stock
Oct 03 2022	BUY Exercise of in-the-money or at-the-money derivatives securities	-	3,148 Added 4.46%	67,424 Common Stock
Jul 01 2022	BUY Grant, award, or other acquisition	-	23,653 Added 26.9%	64,276 Common Stock
Apr 01 2022	BUY Grant, award, or other acquisition	-	4,629 Added 10.23%	40,623 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	4,021 Added 10.05%	35,994 Common Stock
Oct 01 2021	BUY Grant, award, or other acquisition	-	2,912 Added 8.35%	31,973 Common Stock
Jul 01 2021	BUY Grant, award, or other acquisition	-	2,840 Added 8.9%	29,061 Common Stock
Apr 01 2021	BUY Grant, award, or other acquisition	-	2,581 Added 8.96%	26,221 Common Stock
Nov 19 2020	BUY Open market or private purchase	-	17,730 Added 42.86%	23,640 Common Stock
Nov 05 2020	BUY Grant, award, or other acquisition	-	5,910 Added 50.0%	5,910 Common Stock

Also insider at

ARDX

ARDELYX, INC. Healthcare

Director

NVAX

NOVAVAX INC Healthcare

SGMT

Sagimet Biosciences Inc.

Director

RJR